Condition: Alcohol-related Liver Disease · Liver Diseases · Sponsor: Henry Ford Health System
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
This description comes directly from the study's public registry record.
Matthew Melican · 3138744656 · mmelica1@hfhs.org
Jessica Mellinger, MD · 3134281536 · jmellin2@hfhs.org
Always discuss trial participation with your own doctor first.
| Henry Ford Health | Detroit, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06269510